📋 Tender Overview
Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient Emtricitabine + Rilpivirine + Tenofovir disoproxil fumarate, ATC J05AR08 for the period September 1st, 2026 - August 31st, 2028